SENSEX
NIFTY
GOLD
USD/INR

Weather

image 28    C

Economy News

The Economic Times

Economy / The Economic Times

details

Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales

Moderna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-than-expected Q2 revenue but aims for a significant share of Europe's respiratory vaccine market with its mCombriax launch in 2027. Investors are now focused on the company's diversified pipeline beyond COVID-19.

2 May 2026 12:38 am